Paper Details

  1. Home
  2. Paper Details

Diagnosis and fluoxetine treatment of compulsive behavior disorder of adults with mental retardation.

Author: BodfishJ W, MadisonJ T

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

In a study of 16 individuals with intellectual disability and behavioral problems, those who met criteria for compulsive behavior disorder showed improvement after taking fluoxetine (7 out of 10). None of the comparison group showed improvement. The study also suggests that repetitive movements (stereotypies) may be related to compulsive behaviors and response to fluoxetine.
Paper Details　
Original Abstract of the Article :
A set of research diagnostic criteria was developed to identify potential obsessive-compulsive disorders among individuals with mental retardation and aberrant behaviors. The behavior disorders of 10 subjects who met criteria for compulsive behavior disorder and 6 subjects who did not (comparison su...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/8292312

データ提供：米国国立医学図書館（NLM）

Fluoxetine Treatment for Compulsive Behavior Disorder in Adults with Mental Retardation

This research explores the use of fluoxetine, a selective serotonin reuptake inhibitor (SSRI), in treating compulsive behavior disorder (CBD) in adults with mental retardation. The researchers developed a set of diagnostic criteria for CBD in this population and conducted an open-trial study using fluoxetine. They found that a significant proportion of subjects with CBD responded favorably to fluoxetine treatment, while comparison subjects did not. The study also suggested a possible link between motor stereotypies, compulsive behaviors, and response to fluoxetine.

Understanding the Brain: Targeting Serotonin Pathways

This study underscores the potential of SSRIs, such as fluoxetine, in treating CBD in adults with mental retardation. The findings suggest that fluoxetine may be effective in modulating serotonin pathways involved in compulsive behavior. Think of it like a desert oasis – fluoxetine acts like a water source, providing relief from the arid conditions of compulsive behaviors.

Supporting Individuals with Mental Retardation: Finding Effective Treatments

CBD can significantly impact the quality of life of individuals with mental retardation. This research offers hope for individuals with CBD, suggesting that fluoxetine may be a valuable treatment option. The study emphasizes the importance of developing tailored treatments for this population, considering the unique challenges they face. Just as a camel adapts to the harsh desert environment, individuals with mental retardation may require specific interventions to address their individual needs and enhance their well-being.

Dr.Camel's Conclusion

This study explores the potential of fluoxetine in treating compulsive behavior disorder in adults with mental retardation, suggesting that this medication may be a valuable treatment option. The findings highlight the importance of tailoring treatments to the specific needs of this population, acknowledging the unique challenges they face. Just as the desert presents a diverse range of environments, so too do individuals with mental retardation. By understanding their unique needs and finding effective treatments, we can help them navigate their journey towards a better quality of life.

Date :
  1. Date Completed 1994-02-25
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

8292312

DOI: Digital Object Identifier

8292312

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.